Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis

Wyeth is now a wholly owned subsidiary of Pfizer300 enrolled

Overview

In Spain, there is little data available concerning the evolution and treatment of Psoriatic Arthritis by rheumatologists and dermatologists. This study is designed to obtain more data about the clinical and therapeutic management of Psoriatic Arthritis in Dermatology and Rheumatology Medical centers.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Psoriatic Arthritis

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. patients older than 18 years with a psoriatic arthritis diagnosis that go to dermatologic and/or rheumatologic centers or primary care centers. 2. patients that receive pharmacologic treatment for their condition 3. patients that give their written consent to participate

Outcomes

Primary Outcomes

Determine diagnosis and evolution time of patients

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.